The effects of botulinum toxin type A on muscle blood perfusion and metabolism.

作者: Damir B. Matic , Ting Y. Lee , R Glenn Wells , Bing S. Gan

DOI: 10.1097/01.PRS.0000287135.17291.2F

关键词:

摘要: Background: Botulinum toxin type A is approved by the U.S. Food and Drug Administration for treatment of facial rhytides. However, complete spectrum action botulinum has not yet been completely defined. Little known about metabolism muscle after injection. This information may give insight into additional effects have on muscle. The authors assessed influence using dynamic investigative techniques. Methods: Twenty New Zealand White rabbits were divided control, paralysis, sham groups. Masseter paralysis was achieved with A. Dynamic computed tomographic positron emission scans obtained. blood flow, volume, permeability surface, mean transit time glucose uptake measured. Results: Eighteen animals completed study. perfusion showed consistent results across all parameters. Blood surface significantly increased at weeks 4 8 paralyzed side. Mean week decreased Positron that injected muscles in group tended to compared untreated muscles. Conclusions: injection increases parameters a transient period. increase similar duration interval A-induced paralysis. These changes identified fashion represent calcitonin gene-related peptide release.

参考文章(24)
Frédéric A. Meunier, Cesare Colasante, Lucette Faille, Myriam Gastard, Jordi Molgó, Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin. Pflügers Archiv: European Journal of Physiology. ,vol. 431, ,(1996) , 10.1007/BF02346386
Suzanne Berry, Honey I've shrunk biomedical technology! Trends in Biotechnology. ,vol. 20, pp. 3- 4 ,(2002) , 10.1016/S0167-7799(01)01901-1
Jens J. von Lindern, Bernd Niederhagen, Thorsten Appel, Stefan Bergé, Rudolf H. Reich, Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plastic and Reconstructive Surgery. ,vol. 107, pp. 327- 332 ,(2001) , 10.1097/00006534-200102000-00004
DENISE VAN ROSSUM, UWE-KARSTEN HANISCH, RÉMI QUIRION, Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors Neuroscience & Biobehavioral Reviews. ,vol. 21, pp. 649- 678 ,(1997) , 10.1016/S0149-7634(96)00023-1
Olga Tarabal, Jordi Calderó, Joan Ribera, Albert Sorribas, Ricard López, Jordi Molgó, Josep E. Esquerda, Regulation of motoneuronal calcitonin gene-related peptide (CGRP) during axonal growth and neuromuscular synaptic plasticity induced by botulinum toxin in rats. European Journal of Neuroscience. ,vol. 8, pp. 829- 836 ,(1996) , 10.1111/J.1460-9568.1996.TB01269.X
Bahman Guyuron, Tarvez Tucker, Jennifer Kriegler, Botulinum Toxin A and Migraine Surgery Plastic and Reconstructive Surgery. ,vol. 112, pp. 171S- 173S ,(2003) , 10.1097/01.PRS.0000082206.71638.E9
Irena Levitan, Sarah S. Garber, Voltage-dependent inactivation of volume-regulated Cl − current in human T84 colonic and B-cell myeloma cell lines Pflügers Archiv: European Journal of Physiology. ,vol. 431, pp. 297- 299 ,(1995) , 10.1007/BF00410203
Gary E. Borodic, Michael Joseph, Laurie Fay, David Cozzolino, Robert J. Ferrante, Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 12, pp. 392- 399 ,(1990) , 10.1002/HED.2880120504